Intravenous-Morphine and Glucagon-Usage Enhanced MR Cholangiography
Phase 4
- Conditions
- Liver Disease
- Registration Number
- NCT00155376
- Lead Sponsor
- National Taiwan University Hospital
- Brief Summary
Morphine can induce constriction of sphincter of oddi and glucagon can facilitate bile secretion and dilatation of bile duct. We conduct this randomized double blinded study to evaluate the effect of enhancement in MRCP using intravenous morphine and glucagon.
- Detailed Description
Morphine can induce constriction of sphincter of oddi and glucagon can facilitate bile secretion and dilatation of bile duct. We conduct this randomized double blinded study to evaluate the effect of enhancement in MRCP using intravenous morphine and glucagon.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
- normal volunteer
- living liver donor
Exclusion Criteria
- COPD
- chronic liver disease
- hypersensitive to glucagon
- DM
- insulinoma
- glucagonoma
- pregnancy
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method MRCP visibility
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
National Taiwan University Hospital
🇨🇳Taipei, province of Taiwan, Taiwan